WCN26-7388 Case series of pregnancy-associated thrombotic microangiopathy diagnosed as postpartum fulminant HELLP syndrome and atypical hemolytic uremic syndrome

Read full text Summarise with VIRAT
Authors: Tomoyuki Otsuka, Yuya Sasatsuki, Mikoto Fujishiro, Mai Akimoto, Yukako Umezawa, Maiko Nakayama, Masahiro Muto, Hisatsugu Takahara, Yusuke Suzuki, Hitoshi Suzuki
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pregnancy-associated thrombotic microangiopathy (TMA) occurs in 1 in 25,000 births, accounting for 8-18% of all TMA cases. It is necessary to differentiate from thrombotic thrombocytopenic purpura, HELLP syndrome, anti-phospholipid antibody syndrome, atypical hemolytic uremic syndrome (aHUS). However, because these pathogenesis are similar, differentiation is often difficult. Pregnancy-associated TMA can be fatal if it becomes severe, thus early diagnosis and treatment intervention are essential.

Fields of Study & Subjects

Complement system in diseases Pregnancy and preeclampsia studies Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105435–105435
Publication date
25 March 2026
Language
EN